Literature DB >> 5547281

Ventilatory mechanics and expiratory flow limitation during exercise in patients with obstructive lung disease.

W A Potter, S Olafsson, R E Hyatt.   

Abstract

The interrelationships among transpulmonary pressure, flow, and volume during exhausting exercise were studied in 12 males with chronic obstructive lung disease. Expiratory pressure during exercise was compared with flow-limiting pressure (P(max)) measured at rest. In 11 patients, expiratory pressure during exercise exceeded P(max), indicating that ventilation became mechanically inefficient. P(max) values of the patients were lower than those of normal subjects. Evidence of expiratory flow augmentation during exercise was noted in two subjects. Since 10 subjects achieved maximal expiratory flow predicted from flow-volume curves when heart rate was not maximal, we conclude that exercise capacity in most subjects was clearly limited by the deranged ventilatory apparatus. Elevations in mean intrathoracic pressure during exercise also may interfere with venous return and impose an additional limitation.

Entities:  

Mesh:

Year:  1971        PMID: 5547281      PMCID: PMC292006          DOI: 10.1172/JCI106563

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Exercise ventilatory patterns in normal subjects and patientws with airway obstruction.

Authors:  A K Pierce; D Luterman; J Loudermilk; G Blomqvist; R L Johnson
Journal:  J Appl Physiol       Date:  1968-09       Impact factor: 3.531

2.  Flow-volume curves during quiet breathing, maximum voluntary ventilation, and forced vital capacities in patients with obstructive lung disease.

Authors:  T Takishima; G Grimby; W Graham; R Knudson; P T Macklem; J Mead
Journal:  Scand J Respir Dis       Date:  1967

3.  Ventilatory mechanics and expiratory flow limitation during exercise in normal subjects.

Authors:  S Olafsson; R E Hyatt
Journal:  J Clin Invest       Date:  1969-03       Impact factor: 14.808

4.  Mechanical properties of the lung in experimental pulmonary emphysema.

Authors:  S S Park; I P Goldring; C S Shim; M H Williams
Journal:  J Appl Physiol       Date:  1969-06       Impact factor: 3.531

5.  Elasticity of human lungs in relation to age.

Authors:  J M Turner; J Mead; M E Wohl
Journal:  J Appl Physiol       Date:  1968-12       Impact factor: 3.531

6.  Rigidity of tracheae and bronchi during muscular constriction.

Authors:  C R Olsen; A E Stevens; M B McIlroy
Journal:  J Appl Physiol       Date:  1967-07       Impact factor: 3.531

7.  Relationship of air flow to pressure during maximal respiratory effort in man.

Authors:  R E Hyatt; R E Flath
Journal:  J Appl Physiol       Date:  1966-03       Impact factor: 3.531

8.  Determinants of maximal expiratory flow from the lungs.

Authors:  N B Pride; S Permutt; R L Riley; B Bromberger-Barnea
Journal:  J Appl Physiol       Date:  1967-11       Impact factor: 3.531

9.  Significance of the relationship between lung recoil and maximum expiratory flow.

Authors:  J Mead; J M Turner; P T Macklem; J B Little
Journal:  J Appl Physiol       Date:  1967-01       Impact factor: 3.531

10.  Effect of gas compression on pulmonary pressure, flow, and volume relationship.

Authors:  R H Ingram; D P Schilder
Journal:  J Appl Physiol       Date:  1966-11       Impact factor: 3.531

View more
  25 in total

1.  Inspiratory work imposed by continuous positive airway pressure (CPAP) machines: the effect of CPAP level and endotracheal tube size.

Authors:  J L Moran; S Homan; M O'Fathartaigh; M Jackson; P Leppard
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

2.  Patterns of dynamic hyperinflation during exercise and recovery in patients with severe chronic obstructive pulmonary disease.

Authors:  I Vogiatzis; O Georgiadou; S Golemati; A Aliverti; E Kosmas; E Kastanakis; N Geladas; A Koutsoukou; S Nanas; S Zakynthinos; C Roussos
Journal:  Thorax       Date:  2005-06-17       Impact factor: 9.139

3.  Portable oxygen and exercise tolerance in patients with chronic hypoxic cor pulmonale.

Authors:  R J Leggett; D C Flenley
Journal:  Br Med J       Date:  1977-07-09

4.  Effect of maximum ventilation on abdominal muscle relaxation rate.

Authors:  D Kyroussis; G H Mills; M I Polkey; C H Hamnegard; S Wragg; J Road; M Green; J Moxham
Journal:  Thorax       Date:  1996-05       Impact factor: 9.139

5.  Impact of pulmonary system limitations on locomotor muscle fatigue in patients with COPD.

Authors:  Markus Amann; Mark S Regan; Majd Kobitary; Marlowe W Eldridge; Urs Boutellier; David F Pegelow; Jerome A Dempsey
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-05       Impact factor: 3.619

6.  Impaired central hemodynamics in chronic obstructive pulmonary disease during submaximal exercise.

Authors:  Joshua R Smith; Bruce D Johnson; Thomas P Olson
Journal:  J Appl Physiol (1985)       Date:  2019-07-11

7.  Influence of expiratory flow-limitation during exercise on systemic oxygen delivery in humans.

Authors:  A Aliverti; R L Dellacà; P Lotti; S Bertini; R Duranti; G Scano; J Heyman; A Lo Mauro; A Pedotti; P T Macklem
Journal:  Eur J Appl Physiol       Date:  2005-08-05       Impact factor: 3.078

8.  Exercise responses in patients treated for pulmonary tuberculosis by thoracoplasty.

Authors:  M S Phillips; W J Kinnear; D Shaw; J M Shneerson
Journal:  Thorax       Date:  1989-04       Impact factor: 9.139

9.  Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study.

Authors:  Benjamin M Smith; Steven M Kawut; David A Bluemke; Robert C Basner; Antoinette S Gomes; Eric Hoffman; Ravi Kalhan; João A C Lima; Chia-Ying Liu; Erin D Michos; Martin R Prince; LeRoy Rabbani; Daniel Rabinowitz; Daichi Shimbo; Steven Shea; R Graham Barr
Journal:  Circulation       Date:  2013-03-14       Impact factor: 29.690

Review 10.  Hyperinflation and its management in COPD.

Authors:  Luis Puente-Maestu; William W Stringer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.